Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Thalidomide Plus Peginterferon and Ribavirin in Patients With Interferon Resistance (TRITAL)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2009 by Valme University Hospital.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
University of Seville
Information provided by:
Valme University Hospital
ClinicalTrials.gov Identifier:
NCT00856804
First received: March 3, 2009
Last updated: March 5, 2009
Last verified: March 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2012
  Estimated Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)